MorphoSys AG revenue breakdown overview

MorphoSys AG revenue for the last year amounted to 259.46 M USD, the most of which — 257.61 M USD — came from its highest performing source at the moment, Innovative Cancer Medicines, the year earlier bringing 292.45 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought MorphoSys AG 228.63 M USD.